Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous SARS-CoV-2 Vaccine Schedules in Argentina
NCT05027672Phase 2Unknown
- Sponsor
- Ministerio de Salud de la Ciudad de Buenos Aires
- Start
- Jul 2021
- Primary completion
- Aug 2021
- Modality
- Viral Vector Vaccines, Viral Vectors, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19, rAd26, elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Ministerio de Salud de la Ciudad de Buenos Aires. Status: unknown.
02
Drugs
ChAdOx1 nCoV-19rAd26elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05027672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027672.